Ultima Genomics and Hamilton Partner to Automate Sequencing Workflows
Event summary
- Ultima Genomics and Hamilton announced a global partnership on February 25, 2026 to automate sample preparation and amplification workflows for Ultima's sequencing systems.
- The collaboration will integrate Ultima's technology with Hamilton's Microlab® STAR™ liquid handling platform.
- The partnership aims to improve lab operations, reduce hands-on time, and support production-scale sequencing.
- David Peoples, Chief Business and Financial Officer of Ultima Genomics, and Michael Mouradian, Vice President of Scientific Strategy & Market Development at Hamilton, highlighted the strategic importance of the collaboration.
The big picture
This partnership addresses a critical bottleneck in production-scale genomics by delivering complete workflow automation. It underscores Ultima's mission to expand access to sequencing at unprecedented scale, while Hamilton's automation expertise enables laboratories worldwide to adopt scalable NGS workflows with improved efficiency and reproducibility. The collaboration is part of a broader trend towards integrating advanced automation technologies to enhance genomic research and clinical applications.
What we're watching
- Market Adoption
- How quickly labs will adopt the automated workflows and whether this will drive significant cost reductions in sequencing.
- Competitive Response
- Whether competitors will respond with similar automation partnerships or alternative solutions.
- Technological Integration
- The pace at which Ultima and Hamilton can develop and deploy automation scripts for various library preparation approaches.
Related topics
